TGFB1 and breast cancer: In this regard, a recent report indicated that a prolonged TGF-β exposure promoted stable EMT in mammary epithelial and carcinoma cells, by triggering the mTOR pathway; this stable EMT phenotype contributed to controlling cancer cell stemness drug resistance of breast cancer cells [26].